Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of schizophrenia or schizoaffective disorder.
Inpatients with acute exacerbation of psychotic symptoms.
Patients with a minimum score of 40 on the BPRS scale (1-7).
You may not be if
Concurrent treatment with antipsychotic agents at study drug initiation (within 12 hours prior to study drug initiation); for depot agents a period of two weeks or one cycle, whichever is the longer, must occur between last administration and study drug initiation.
Treatment with antidepressants or mood stabilizers within 7 days of start of ziprasidone.
Patients currently receiving clozapine.
Patients at immediate risk of committing harm to self or others.
Clareo Health | A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective Disorder
